{"content":"<li class=\"n-box-item date-title\" data-end=\"1519880399\" data-start=\"1519794000\" data-txt=\"Monday, December 23, 2019\">Wednesday, February 28, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3335442\" data-ts=\"1519863354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LB\" target=\"_blank\">LB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335442-l-brands-posts-q4-beat-guides-q1-full-year-earnings-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">L Brands posts Q4 beat but guides Q1, full-year earnings below consensus</a></h4><ul>     <li>L&nbsp;Brands (NYSE:<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a>) <font color='red'>-7.5%</font> after-hours despite beating <a href=\"https://seekingalpha.com/news/3335388-l-brands-beats-0_06-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenue expectations, as the fashion retailer issues downside guidance for Q1 and the full year.</li>     <li>Q4 adjusted EPS of $2.11 beat estimates and topped the year-earlier quarter's $2.03, and sales rose to a better than expected $4.82B compared with $4.49B a year ago.</li>     <li>But company guidance is disappointing: LB sees Q1 EPS of $0.15-$0.20 vs. $0.31 analyst consensus estimate and FY 2018 EPS of $2.95-$3.25 vs. $3.43 consensus.</li><li>LB also announces a proposed $500M offering of senior notes due 2028  for the redemption of outstanding senior notes due next year.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3335442\" data-linked=\"L Brands posts Q4 beat but guides Q1, full-year earnings below consensus\" data-tweet=\"$LB - L Brands posts Q4 beat but guides Q1, full-year earnings below consensus https://seekingalpha.com/news/3335442-l-brands-posts-q4-beat-guides-q1-full-year-earnings-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3335442-l-brands-posts-q4-beat-guides-q1-full-year-earnings-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335419\" data-ts=\"1519857314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335419-after-hours-gainers-losers-2-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (2/28/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='green'>+22.5%</font>. <a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a> <font color='green'>+15.9%</font>. <a href='https://seekingalpha.com/symbol/QEP' title='QEP Resources, Inc.'>QEP</a> <font color='green'>+12.5%</font>. <a href='https://seekingalpha.com/symbol/BLDR' title='Builders FirstSource, Inc.'>BLDR</a> <font color='green'>+6.9%</font>. <a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color='green'>+6.9%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a> <font color='red'>-29.0%</font>. <a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a> <font color='red'>-13.9%</font>. <a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-8.8%</font>. <a href='https://seekingalpha.com/symbol/RRD' title='R.R. Donnelley & Sons Company'>RRD</a> <font color='red'>-8.5%</font>. <a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a> <font color='red'>-7.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335419\" data-linked=\"After Hours Gainers / Losers (2/28/2018)\" data-tweet=\"$NVAX $NVAX $DDD - After Hours Gainers / Losers (2/28/2018) https://seekingalpha.com/news/3335419-after-hours-gainers-losers-2-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3335419-after-hours-gainers-losers-2-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335408\" data-ts=\"1519856520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335408-3d-systemsplus-14_7-after-delaying-q4-report-includes-upside-prelim-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D Systems +14.7% after delaying Q4 report, includes upside prelim results</a></h4><ul><li>        3D Systems (NYSE:<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a>)&nbsp;<font color='green'>soars 14.7%</font>&nbsp;after announcing the company will <a href=\"https://seekingalpha.com/pr/17088392-3d-systems-reports-preliminary-fourth-quarter-full-year-2017-financial-results-reschedules\" target=\"_blank\">delay filing its 10-K</a> and will now hold its Q4 and FY17 call on March 14.</li><li>               Company says the delay is related to accounting for product warranty revenue and costs.&nbsp;</li><li>               Preliminary results have revenue from $176M to $178M (consensus: $162.23M) and EPS of $0.03 to $0.05 (consensus: $0.02).&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17088392-3d-systems-reports-preliminary-fourth-quarter-full-year-2017-financial-results-reschedules\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335144-3d-printing-stocks-drop-stratasys-earnings\" target=\"_blank\">3D printing stocks drop after Stratasys earnings</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335408\" data-linked=\"3D Systems +14.7% after delaying Q4 report, includes upside prelim results\" data-tweet=\"$DDD - 3D Systems +14.7% after delaying Q4 report, includes upside prelim results https://seekingalpha.com/news/3335408-3d-systemsplus-14_7-after-delaying-q4-report-includes-upside-prelim-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3335408-3d-systemsplus-14_7-after-delaying-q4-report-includes-upside-prelim-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335404\" data-ts=\"1519855914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335404-dealreporter-microchip-tech-deal-value-microsemi-69-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dealreporter: Microchip Tech deal could value Microsemi at $69/share</a></h4><ul><li>        Microchip Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>) could offer Microsemi (NASDAQ:<a href='https://seekingalpha.com/symbol/MSCC' title='Microsemi Corporation'>MSCC</a>) a deal that values it at $68 to $69 per share in cash, according to the Dealreporter via Bloomberg First Word.</li><li>               Microsemi shareholders could refuse the deal since the offer falls below the $70/share value estimated by analysts.&nbsp;</li><li>               Microsemi previously had talks with Renesas, which walked away, and Qorvo.&nbsp;</li><li>               Microchip shares are&nbsp;<font color='green'>up 1.2%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335166-needham-microsemi-acquisition-immediately-accretive-mchp\" target=\"_blank\">Needham: Microsemi acquisition could be \"immediately accretive\" for MCHP</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335404\" data-linked=\"Dealreporter: Microchip Tech deal could value Microsemi at $69/share\" data-tweet=\"$MCHP $MCHP $MSCC - Dealreporter: Microchip Tech deal could value Microsemi at $69/share https://seekingalpha.com/news/3335404-dealreporter-microchip-tech-deal-value-microsemi-69-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3335404-dealreporter-microchip-tech-deal-value-microsemi-69-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335392\" data-ts=\"1519855287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335392-mylan-q4-top-line-off-1-earnings-down-42-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan Q4 top line off 1%; earnings down 42%; shares up 1% after hours</a></h4><ul><li>Mylan N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>)<a href=\"https://seekingalpha.com/pr/17088331-mylan-reports-full-year-fourth-quarter-2017-results-provides-2018-guidance\" target=\"_blank\"> Q4 results</a> ($M): Revenues: 3,238.9 (-0.9%); North America: 1,302.9 (-16.7%); Europe: 1,071.2 (+15.5%).</li><li>Net Income: 244.3 (-41.5%); non-GAAP net income: 765.3 (-9.1%); EPS: 0.46 (-41.0%); non-GAAP EPS: 1.43 (-8.9%).</li><li>EBITDA: 962.2 (+9.5%); non-GAAP EBITDA: 1,123.6 (-7.3%).</li><li><strong>2018 guidance</strong>: Revenues: $11.75B - 13.25B; non-GAAP EBITDA: $4.0B - 4.5B; non-GAAP net income: $2.7B - 2.9B; non-GAAP EPS: $5.20 - 5.60.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335392\" data-linked=\"Mylan Q4 top line off 1%; earnings down 42%; shares up 1% after hours\" data-tweet=\"$MYL - Mylan Q4 top line off 1%; earnings down 42%; shares up 1% after hours https://seekingalpha.com/news/3335392-mylan-q4-top-line-off-1-earnings-down-42-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3335392-mylan-q4-top-line-off-1-earnings-down-42-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335390\" data-ts=\"1519855218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335390-boxminus-10_6-on-q4-report-in-line-revenue-downside-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box -10.6% on Q4 report with in-line revenue, downside revenue guidance</a></h4><ul><li>        Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>)&nbsp;<font color='red'>plunges 10.6%</font>&nbsp;aftermarket following Q4 results that met revenue estimates with a 24.3% Y/Y increase and beat on EPS, narrowing the net loss by four cents on the year to $0.24.&nbsp;</li><li>        Box changed from ASC 605 to ASC 606 and that's reflected in the guidance.&nbsp;</li><li>               Q1 guidance: Revenue expected from $139M to $140M (consensus: $144.30M). Under old 605 standard, revenue was expected from $142M to $143M, which makes either scenario a downside. In-line EPS expected from -$0.09 to -$0.048 in ASC 606 and 605 (consensus: -$0.08).&nbsp;</li><li>               FY18 guidance: Downside revenue expected from $602M to $608M in 606 (consensus: $625.67) and $613M to $619M in 605.&nbsp; In-line EPS from -$0.20 to -$0.16 in 606 (consensus: -$0.20) and downside EPS from -$0.28 to -$0.24 in 605.&nbsp;</li><li>               Key metrics: Billings, $204.6M (+28% Y/Y); Deferred revenue, $320.9M (+33%); cash flow from operations, $48.7M (+$34M); operating expenses, $133.9M; FCF, $13.3M (+$3.2M); cash and equivalents, $208.1M.&nbsp;</li><li>               Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://www.boxinvestorrelations.com/home/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17088168-box-reports-record-revenue-506-million-fiscal-year-2018-27-percent-year-year-delivers\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335293-box-beats-0_02-revenue-line\" target=\"_blank\">Box beats by $0.02,  revenue in-line</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335390\" data-linked=\"Box -10.6% on Q4 report with in-line revenue, downside revenue guidance\" data-tweet=\"$BOX - Box -10.6% on Q4 report with in-line revenue, downside revenue guidance https://seekingalpha.com/news/3335390-boxminus-10_6-on-q4-report-in-line-revenue-downside-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3335390-boxminus-10_6-on-q4-report-in-line-revenue-downside-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335393\" data-ts=\"1519855182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QEP\" target=\"_blank\">QEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335393-qep-resourcesplus-6-on-renewed-push-to-permian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QEP Resources +6% on renewed push to the Permian</a></h4><ul>     <li>QEP&nbsp;Resources (NYSE:<a href='https://seekingalpha.com/symbol/QEP' title='QEP Resources, Inc.'>QEP</a>)&nbsp;<font color='green'>+6.1%</font> after-hours as it reports a surprise <a href=\"https://seekingalpha.com/news/3335313-qep-resources-beats-1_20-beats-revenue\" target=\"_blank\">Q4 profit</a> as well as better than expected revenues, and announces strategic initiatives to transition to a pure-play Permian Basin company.</li>     <li>QEP says it has engaged financial advisors to assist with the sale of its Williston and Uinta basin assets, with data rooms expected to be opened in late March or early April, and expects to market its Haynesville and other remaining non-Permian assets in H2 2018; the company also authorizes a $1.25 stock buyback program.</li>     <li>QEP says it anticipates 2018 capex of $1.075B, with 65% to be directed toward the Permian Basin.</li>     <li>During Q4, QEP's production was 12.1M boe  vs. 13.7M boe for theyear-ago quarter, although oil output rose 7% while natural gas and NGL production fell by a respective 22% and 23%; total FY 2017 production was 53.1M boe (37% oil), with Permian Basin oil production rising 52% Y/Y to a record 6.1M bbl.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335393\" data-linked=\"QEP Resources +6% on renewed push to the Permian\" data-tweet=\"$QEP - QEP Resources +6% on renewed push to the Permian https://seekingalpha.com/news/3335393-qep-resourcesplus-6-on-renewed-push-to-permian?source=tweet\" data-url=\"https://seekingalpha.com/news/3335393-qep-resourcesplus-6-on-renewed-push-to-permian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335378\" data-ts=\"1519854211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLIT\" target=\"_blank\">HLIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335378-harmonicplus-10_7-revenues-top-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmonic +10.7% as revenues top Street</a></h4><ul>   <li>Harmonic (NASDAQ:<a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a>) has <font color='green'>jumped 10.7%</font> in postmarket trading after revenues beat expectations in <a href=\"https://seekingalpha.com/news/3335304-harmonic-misses-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a> despite a double-digit decline.</li>    <li>Net loss widened slightly on a GAAP basis, to $11.8M, and non-GAAP earnings swung to a $0.4M loss from a year-ago gain of $6.7M.</li>    <li>Bookings, meanwhile, were up to $122.9M from $116.9M; backlog and deferred revenue at quarter's end was up to $224.4M from a year-ago $188.4M.</li>    <li>Revenue breakout: Product, $67.99M (down 17.4%); Service, $34.99M (up 5.4%).</li>    <li>Cash and short-term investments came to $57M, down from the prior year's $62.6M.</li>    <li>For Q1, it's guiding to net revenue of $83M-$93M, gross margin of 52-53%, and EPS of -$0.10 to -$0.01.</li>    <li>For the full year, it's forecasting revenue of $380M-$430M, gross margin of 51-53%, and EPS of -$0.18 to $0.25.</li>    <li><a href=\"http://www.harmonicinc.com\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17088180-harmonic-announces-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3335378\" data-linked=\"Harmonic +10.7% as revenues top Street\" data-tweet=\"$HLIT - Harmonic +10.7% as revenues top Street https://seekingalpha.com/news/3335378-harmonicplus-10_7-revenues-top-street?source=tweet\" data-url=\"https://seekingalpha.com/news/3335378-harmonicplus-10_7-revenues-top-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335357\" data-ts=\"1519853496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335357-salesforce-dips-0_5-on-q4-beats-upside-guidanceplus-26-subscription-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce dips 0.5% on Q4 beats, upside guidance, +26% subscription growth</a></h4><ul><li>        Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) shares&nbsp;<font color='red'>drop 0.5%</font>&nbsp;aftermarket on Q4 results that beat estimates with a 24.5% Y/Y revenue growth. Upside Q1 guidance has revenue from $2.925B to $2.935B (consensus: $2.9B) and EPS from $0.43 to $0.44 (consensus: $0.37).</li><li>               Upside FY19 guidance has revenue from $12.6B to $12.65B (consensus: $12.55B) and EPS from $2.02 to $2.04 (consensus: $1.75).&nbsp;</li><li>               Key metrics: Subscription and support revenue, $2.66B (+26%); Professional services and other revenue, $196M (+7%); operating cash flow, $1.05B (+49%); total operating expenses, $2.04B; cash and equivalents, $4.52B; deferred revenue, $7.09B (+28%); unbilled deferred revenue, $13.3B (+48%); total current and noncurrent debt, $1.72B.&nbsp;</li><li>               Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"http://investor.salesforce.com/about-us/investor/overview/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17088170-salesforce-announces-record-fourth-quarter-full-year-fiscal-2018-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335295-salesforce-com-beats-0_01-beats-revenue\" target=\"_blank\">Salesforce.com beats by $0.01, beats on revenue</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335357\" data-linked=\"Salesforce dips 0.5% on Q4 beats, upside guidance, +26% subscription growth\" data-tweet=\"$CRM - Salesforce dips 0.5% on Q4 beats, upside guidance, +26% subscription growth https://seekingalpha.com/news/3335357-salesforce-dips-0_5-on-q4-beats-upside-guidanceplus-26-subscription-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3335357-salesforce-dips-0_5-on-q4-beats-upside-guidanceplus-26-subscription-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335352\" data-ts=\"1519853342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335352-novavaxs-nanoflu-shows-positive-effect-in-phase-1-2-study-in-older-adults-shares-up-18-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax&#39;s NanoFlu shows positive effect in Phase 1/2 study in older adults; shares up 18% after hours</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17088178-novavax-nanoflu-vaccine-demonstrates-improved-immune-responses-compared-egg-based-high-dose\" target=\"_blank\">Top-line results</a> from a Phase 1/2 clinical trial assessing Novavax's (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) recombinant flu vaccine NanoFlu in older adults showed a treatment effect over and above the leading egg-based flu vaccine.</li><li>In three H3N2 strains, which accounted for ~3/4 of flu-related hospitalizations this year, NanoFlu produced 47 - 64% higher antibody titers compared to the egg-based high-dose vaccine.</li><li>The company expects to launch a Phase 2 study in Q3.</li><li>Shares are up&nbsp;<font color='green'>18%</font>&nbsp;after hours on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335352\" data-linked=\"Novavax&#39;s NanoFlu shows positive effect in Phase 1/2 study in older adults; shares up 18% after hours\" data-tweet=\"$NVAX - Novavax&#39;s NanoFlu shows positive effect in Phase 1/2 study in older adults; shares up 18% after hours https://seekingalpha.com/news/3335352-novavaxs-nanoflu-shows-positive-effect-in-phase-1-2-study-in-older-adults-shares-up-18-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3335352-novavaxs-nanoflu-shows-positive-effect-in-phase-1-2-study-in-older-adults-shares-up-18-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335342\" data-ts=\"1519852997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECR\" target=\"_blank\">ECR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335342-eclipse-resources-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eclipse Resources beats by $0.02, beats on revenue</a></h4><ul><li>Eclipse Resources (NYSE:<a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a>): Q4 EPS of $0.02 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $104.1M (+24.1% Y/Y) <font color='green'>beats by $4.3M</font>.</li><li>Shares <font color='green'>+1.9%</font>.</li><li><a href='https://seekingalpha.com/pr/17088275-eclipse-resources-corporation-announces-fourth-quarter-full-year-2017-results-increase-first'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335342\" data-linked=\"Eclipse Resources beats by $0.02, beats on revenue\" data-tweet=\"$ECR $ECR-OLD - Eclipse Resources beats by $0.02, beats on revenue https://seekingalpha.com/news/3335342-eclipse-resources-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3335342-eclipse-resources-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335333\" data-ts=\"1519852822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CODI\" target=\"_blank\">CODI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335333-compass-diversified-holdings-beats-0_09-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compass Diversified Holdings beats by $0.09, misses on revenue</a></h4><ul><li>Compass Diversified Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CODI' title='Compass Diversified Holdings'>CODI</a>): Q4 EPS of $0.53 <font color='green'>beats by $0.09</font>.</li><li>Revenue of $348.4M (+9.4% Y/Y) <font color='red'>misses by $2.59M</font>.</li><li>Shares <font color='green'>+1.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17088268-compass-diversified-holdings-reports-fourth-quarter-full-year-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335333\" data-linked=\"Compass Diversified Holdings beats by $0.09, misses on revenue\" data-tweet=\"$CODI - Compass Diversified Holdings beats by $0.09, misses on revenue https://seekingalpha.com/news/3335333-compass-diversified-holdings-beats-0_09-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3335333-compass-diversified-holdings-beats-0_09-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335329\" data-ts=\"1519852757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335329-mylan-teams-up-revance-to-develop-botox-biosimilar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan teams up with Revance to develop Botox biosimilar</a></h4><ul><li>Mylan N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>) inks a global collaboration and license <a href=\"https://seekingalpha.com/pr/17088183-mylan-bring-biosimilar-botox-market-collaboration-license-agreement-revance-therapeutics\" target=\"_blank\">agreement </a>with Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) aimed at developing and commercializing a biosimilar to Allergan's (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>) BOTOX (onabotulinumtoxinA).</li><li>Under the terms of the deal, Mylan will pay Revance $25M upfront, milestones and royalties on net sales. Detailed financial terms are not disclosed.</li><li>Revance will continue to exclusively develop RT002, a long-acting neuromodulator.</li><li>RVNC is up&nbsp;<font color='green'>2%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335329\" data-linked=\"Mylan teams up with Revance to develop Botox biosimilar\" data-tweet=\"$MYL $MYL $RVNC - Mylan teams up with Revance to develop Botox biosimilar https://seekingalpha.com/news/3335329-mylan-teams-up-revance-to-develop-botox-biosimilar?source=tweet\" data-url=\"https://seekingalpha.com/news/3335329-mylan-teams-up-revance-to-develop-botox-biosimilar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335325\" data-ts=\"1519852726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVNC\" target=\"_blank\">RVNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335325-revance-therapeutics-misses-0_17-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revance Therapeutics misses by $0.17, misses on revenue</a></h4><ul><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>): Q4 EPS of -$1.14 <font color='red'>misses by $0.17</font>.</li><li>Revenue of $0.04M (-50.0% Y/Y) <font color='red'>misses by $0.04M</font>.</li><li>Shares <font color='green'>+1.2%</font>.</li><li><a href='https://seekingalpha.com/pr/17088219-revance-releases-fourth-quarter-full-year-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335325\" data-linked=\"Revance Therapeutics misses by $0.17, misses on revenue\" data-tweet=\"$RVNC - Revance Therapeutics misses by $0.17, misses on revenue https://seekingalpha.com/news/3335325-revance-therapeutics-misses-0_17-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3335325-revance-therapeutics-misses-0_17-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335309\" data-ts=\"1519852436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335309-enphase-energy-to-seek-exemption-from-trumps-solar-tariff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase Energy to seek exemption from Trump&#39;s solar tariff</a></h4><ul>     <li>Add Enphase Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a>) to the list of U.S. solar companies <a href=\"https://www.bloomberg.com/news/articles/2018-02-28/another-u-s-solar-company-seeks-exemption-from-trump-s-tariff\" target=\"_blank\">seeking an exemption</a> from the 30% tariff recently imposed by Pres. Trump, even though it does not make solar panels.</li>     <li>ENPH makes microinverters, which convert energy produced by photovoltaic panels from direct to alternating current, in the U.S. but the company ships the devices to manufacturers in Asia to attach to panels before they are sold in the U.S. - thus they are subject to the tariff.</li>     <li>ENPH soared 19% to 52-week highs in today's trade after reporting its first <a href=\"https://seekingalpha.com/news/3334805-enphase-energy-beats-0_02-beats-revenue\" target=\"_blank\">quarterly profit</a> on an adjusted basis since 2015.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335309\" data-linked=\"Enphase Energy to seek exemption from Trump&#39;s solar tariff\" data-tweet=\"$ENPH - Enphase Energy to seek exemption from Trump&#39;s solar tariff https://seekingalpha.com/news/3335309-enphase-energy-to-seek-exemption-from-trumps-solar-tariff?source=tweet\" data-url=\"https://seekingalpha.com/news/3335309-enphase-energy-to-seek-exemption-from-trumps-solar-tariff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335302\" data-ts=\"1519852305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HABT\" target=\"_blank\">HABT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335302-habit-restaurants-beats-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Habit Restaurants beats by $0.01, misses on revenue</a></h4><ul><li>The Habit Restaurants (NASDAQ:<a href='https://seekingalpha.com/symbol/HABT' title='The Habit Restaurants'>HABT</a>): Q4 EPS of $0.00 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $85.09M (+15.2% Y/Y) <font color='red'>misses by $0.59M</font>.</li><li>Shares <font color='green'>+2.89%</font>.</li><li><a href='https://seekingalpha.com/pr/17088188-habit-restaurants-inc-announces-fourth-quarter-fiscal-year-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335302\" data-linked=\"The Habit Restaurants beats by $0.01, misses on revenue\" data-tweet=\"$HABT - The Habit Restaurants beats by $0.01, misses on revenue https://seekingalpha.com/news/3335302-habit-restaurants-beats-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3335302-habit-restaurants-beats-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335295\" data-ts=\"1519852093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335295-salesforce-com-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce.com beats by $0.01, beats on revenue</a></h4><ul><li>Salesforce.com (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>): Q4 EPS of $0.35 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $2.85B (+24.5% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+1.9%</font>.</li><li><a href='https://seekingalpha.com/pr/17088170-salesforce-announces-record-fourth-quarter-full-year-fiscal-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335295\" data-linked=\"Salesforce.com beats by $0.01, beats on revenue\" data-tweet=\"$CRM - Salesforce.com beats by $0.01, beats on revenue https://seekingalpha.com/news/3335295-salesforce-com-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3335295-salesforce-com-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335278\" data-ts=\"1519851399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPC\" target=\"_blank\">TPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335278-tutor-periniplus-11-after-q4-earnings-beat-keybanc-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tutor Perini +11% after Q4 earnings beat, KeyBanc upgrade</a></h4><ul>     <li>Tutor Perini (<a href='https://seekingalpha.com/symbol/TPC' title='Tutor Perini Corporation'>TPC</a> <font color='green'>+10.9%</font>) soars after KeyBanc <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11275634/keybanc-finds-tutor-perinis-valuation-attractive-upgrad\" target=\"_blank\">upgrades</a> shares to Overweight from Sector Weight with a $28 price target, which was prompted by the company's solid <a href=\"https://seekingalpha.com/news/3334813-tutor-perini-beats-0_04-misses-revenue\" target=\"_blank\">Q4 earnings</a> beat.</li>     <li>TPC's Q4 results showed its highest margin Civil segment rose 54% Y/Y and the $1.4B Newark Airport terminal contract win will drive a book-to-bill above 1x in Q1 2018, the firm says.</li>     <li>TPC completed its second straight year of a free cash flow recovery after many years of poor performance, which KeyBanc says could be attributed to management's efforts on cash collections, including a new incentive comp structure which was introduced last spring.</li>     <li>The company also guided 2018 EPS to $1.90-$2.30, implying 25% Y/Y EPS growth at the midpoint, which may imply it is at the very least \"comfortably achievable\" if not beatable, the firm says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335278\" data-linked=\"Tutor Perini +11% after Q4 earnings beat, KeyBanc upgrade\" data-tweet=\"$TPC - Tutor Perini +11% after Q4 earnings beat, KeyBanc upgrade https://seekingalpha.com/news/3335278-tutor-periniplus-11-after-q4-earnings-beat-keybanc-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3335278-tutor-periniplus-11-after-q4-earnings-beat-keybanc-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335277\" data-ts=\"1519851064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNSL\" target=\"_blank\">CNSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335277-consolidated-offers-directv-now-across-customer-footprint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consolidated offers DirecTV Now across customer footprint</a></h4><ul>   <li>Consolidated Communications (<a href=\"http://seekingalpha.com/symbol/CNSL\" target=\"_blank\">CNSL</a> <font color='red'>-4.2%</font>) says it's <a href=\"https://seekingalpha.com/pr/17088033-consolidated-communications-enhances-video-offerings-launch-directv-now-across-service-area\" target=\"_blank\">offering streaming service DirecTV Now</a> (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-1.2%</font>) to customers across its entire footprint.</li>    <li>Customers will get a free seven-day trial before having to sign up for packages starting at $35 monthly, and may be eligible for more benefits with a prepaid subscription, such as an Amazon Fire TV 4K stick.</li>    <li>Consolidated offers services across a 24-state footprint with a fiber network spanning more than 36,000 route miles. It has more than 117,000 subscribers to its IPTV service, and more than 783,000 data/Internet connections along with 990,000-plus voice customers.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3335277\" data-linked=\"Consolidated offers DirecTV Now across customer footprint\" data-tweet=\"$CNSL $CNSL $T - Consolidated offers DirecTV Now across customer footprint https://seekingalpha.com/news/3335277-consolidated-offers-directv-now-across-customer-footprint?source=tweet\" data-url=\"https://seekingalpha.com/news/3335277-consolidated-offers-directv-now-across-customer-footprint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335276\" data-ts=\"1519850833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYH\" target=\"_blank\">CYH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335276-community-healths-q4-revenue-miss-pressures-shares-down-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Community Health&#39;s Q4 revenue miss pressures shares, down 20%</a></h4><ul><li>Community Health Systems (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='red'>-19.7%</font>) slumps on double normal volume after reporting <a href=\"https://seekingalpha.com/pr/17086692-community-health-systems-inc-announces-fourth-quarter-year-end-2017-results-2018-guidance\" target=\"_blank\">Q4 results</a> that included a revenue shortfall versus consensus that the company says was due to a $591M increase in contractual allowances and a change in its provision for bad debts.</li><li>Net revenues: $3.06B (-31.6%); loss/share: ($17.98) (-999%).</li><li>Non-GAAP EBITDA: $409M (-27.5%).</li><li>Cash flow ops (full-year): $773M (-32.0%).</li><li><strong>2018 guidance</strong>: Revenues: $13.6B - 13.9B; non-GAAP EBITDA: $1.55B - 1.65B; loss/share: ($1.50 - 1.10).</li></ul><div class=\"tiny-share-widget\" data-id=\"3335276\" data-linked=\"Community Health&#39;s Q4 revenue miss pressures shares, down 20%\" data-tweet=\"$CYH - Community Health&#39;s Q4 revenue miss pressures shares, down 20% https://seekingalpha.com/news/3335276-community-healths-q4-revenue-miss-pressures-shares-down-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3335276-community-healths-q4-revenue-miss-pressures-shares-down-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335274\" data-ts=\"1519850559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSPP\" target=\"_blank\">RSPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335274-rsp-permianplus-7-on-strong-production-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RSP Permian +7% on strong production outlook</a></h4><ul>     <li>RSP&nbsp;Permian (<a href='https://seekingalpha.com/symbol/RSPP' title='RSP Permian'>RSPP</a> <font color='green'>+7.2%</font>) surges even after reporting in-line <a href=\"https://seekingalpha.com/news/3334775-rsp-permian-eps-line-beats-revenue\" target=\"_blank\">Q4 earnings</a>, as revenue rose 103% Y/Y to $249M and production soared&nbsp;74%.</li>     <li>RSPP says Q4 production averaged 62.4K boe/day compared to 35.8K boe/day in the year-ago quarter and FY 2017 production jumped 89% Y/Y to 55.25K boe/day (72% oil, 88% liquids) from 29.2K a year earlier.</li><li>RSPP forecasts FY 2018 production to rise 30%-40% Y/Y to  72K-78K boe/day, with planned capex of $815M-$895M after spending $673M in 2017.</li>     <li>At a $50/bbl average oil price, the company expects to generate cash  flow in excess of development spending by Q4 and exit 2018 at less than 2.0x net debt-to-EBITDAX.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335274\" data-linked=\"RSP Permian +7% on strong production outlook\" data-tweet=\"$RSPP - RSP Permian +7% on strong production outlook https://seekingalpha.com/news/3335274-rsp-permianplus-7-on-strong-production-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3335274-rsp-permianplus-7-on-strong-production-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335271\" data-ts=\"1519850092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335271-dollar-posts-1st-monthly-gain-in-four-months\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar posts 1st monthly gain in four months</a></h4><ul><li>Traders began to unwind some of their short dollar exposure on the back of higher yields, and a jump in equity volatility.</li><li>Jay Powell's comments yesterday regarding the state of the economy and monetary policy provided more fuel to the unwind.</li><li>The euro is weaker on the back of softening inflation data, the sterling is being pressured by Brexit negotiations, and the loonie has been lower on NAFTA uncertainty. The yen is the only only major currency up against the dollar this month, primarily on the back of slowing JGB purchases and potential fiscal year-end repatriation flows to Japan.</li><li>Source: Bloomberg</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>, <a href='https://seekingalpha.com/symbol/UDN' title='PowerShares DB USD Bear ETF'>UDN</a>, <a href='https://seekingalpha.com/symbol/USDU' title='WisdomTree Bloomberg U.S. Dollar Bullish ETF'>USDU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335271\" data-linked=\"Dollar posts 1st monthly gain in four months\" data-tweet=\"$UUP $UDN $USDU - Dollar posts 1st monthly gain in four months https://seekingalpha.com/news/3335271-dollar-posts-1st-monthly-gain-in-four-months?source=tweet\" data-url=\"https://seekingalpha.com/news/3335271-dollar-posts-1st-monthly-gain-in-four-months\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335272\" data-ts=\"1519849704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335272-endo-down-7-on-fda-ok-of-sorrentos-ztlido\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endo down 7% on FDA OK of Sorrento&#39;s ZTlido</a></h4><ul><li>Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='red'>-7.3%</font>) slumps almost double normal volume in response the U.S. approval of Sorrento Therapeutics' ZTlido (lidocaine patch) 1.8% for the treatment of pain associated with post herpetic neuralgia (shingles).</li><li>Endo's pharmaceutical unit sells <a href=\"http://www.endo.com/File%20Library/Products/Prescribing%20Information/LIDODERM_prescribing_information.html\" target=\"_blank\">Lidoderm </a>(lidocaine patch) 5% to which Sorrento compared ZTlido to in clinical studies. ZTlido's value proposition is the delivery of a bioequivalent therapeutic dose of lidocaine with a dose load almost 95% less (36 mg/patch vs. 700 mg/patch) which is safer for children and pets and reduces drug waste.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335249-fda-oks-sorrentos-ztlido-phn-related-pain\" target=\"_blank\">FDA OKs Sorrento's ZTlido for PHN-related pain</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335272\" data-linked=\"Endo down 7% on FDA OK of Sorrento&#39;s ZTlido\" data-tweet=\"$ENDP - Endo down 7% on FDA OK of Sorrento&#39;s ZTlido https://seekingalpha.com/news/3335272-endo-down-7-on-fda-ok-of-sorrentos-ztlido?source=tweet\" data-url=\"https://seekingalpha.com/news/3335272-endo-down-7-on-fda-ok-of-sorrentos-ztlido\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335267\" data-ts=\"1519849007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335267-herbalife-takes-victory-lap-after-ackman-throws-in-towel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herbalife takes victory lap after Ackman throws in the towel</a></h4><ul><li>\"Don't be afraid to get to know us,\" says Herbalife (<a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a> <font color='green'>+6.7%</font>) CEO Rich Goudis, following<a href=\"https://seekingalpha.com/news/3335207-ackman-herbalife-cnbc\" target=\"_blank\"> reports Bill Ackman has</a> completely given up on his short position.</li><li>\"The performance and resiliency of our Company is rooted in our purpose to make the world healthier and happier.\"</li><li>Source: <a href=\"https://seekingalpha.com/pr/17088065-statement-herbalife-ceo-rich-goudis\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335267\" data-linked=\"Herbalife takes victory lap after Ackman throws in the towel\" data-tweet=\"$HLF - Herbalife takes victory lap after Ackman throws in the towel https://seekingalpha.com/news/3335267-herbalife-takes-victory-lap-after-ackman-throws-in-towel?source=tweet\" data-url=\"https://seekingalpha.com/news/3335267-herbalife-takes-victory-lap-after-ackman-throws-in-towel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335264\" data-ts=\"1519848301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335264-twitter-rolls-out-long-in-works-bookmarking-feature\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter rolls out long-in-works bookmarking feature</a></h4><ul>   <li>Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='green'>+2.8%</font>) today launched the ability to <a href=\"https://blog.twitter.com/official/en_us/topics/product/2018/an-easier-way-to-save-and-share-tweets.html\" target=\"_blank\">bookmark tweets for later access</a>, a feature often requested by users (if not the feature in highest demand).</li>    <li>It's added a \"share\" icon on each tweet, though which users will be able to bookmark a tweet as well as share it easily through a direct message, for example.</li>    <li>Users had called for the feature since a workaround for saving tweets -- \"favoriting\" them -- was publicly viewable, whereas bookmarks will be private.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335264\" data-linked=\"Twitter rolls out long-in-works bookmarking feature\" data-tweet=\"$TWTR - Twitter rolls out long-in-works bookmarking feature https://seekingalpha.com/news/3335264-twitter-rolls-out-long-in-works-bookmarking-feature?source=tweet\" data-url=\"https://seekingalpha.com/news/3335264-twitter-rolls-out-long-in-works-bookmarking-feature\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335258\" data-ts=\"1519847684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AWSM\" target=\"_blank\">AWSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335258-technology-top-gainers-losers-of-2_55-pm-2-28-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (2/28/18)</a></h4><ul>     <li><strong>Gainers</strong>:IFON <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/VEEV' title='Veeva Systems Inc.'>VEEV</a> <font color='green'>+13%</font></li>     <li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ROG' title='Rogers Corporation'>ROG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SE' title='Sea Ltd'>SE</a> <font color='red'>-13%</font>.<strong> </strong></li><strong>  </strong>     <strong> &nbsp;</strong>     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3335258\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (2/28/18)\" data-tweet=\"$AWSM $AWSM $MYSZ - Technology - Top Gainers / Losers as of 2.55 pm (2/28/18) https://seekingalpha.com/news/3335258-technology-top-gainers-losers-of-2_55-pm-2-28-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3335258-technology-top-gainers-losers-of-2_55-pm-2-28-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335257\" data-ts=\"1519847674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYV\" target=\"_blank\">LYV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335257-reported-dallas-cowboys-ticketing-move-may-ding-live-nation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reported Dallas Cowboys ticketing move may ding Live Nation</a></h4><ul>   <li>Live Nation Entertainment (<a href=\"http://seekingalpha.com/symbol/LYV\" target=\"_blank\">LYV</a> <font color='red'>-4.3%</font>) -- already lower today after its <a href=\"https://seekingalpha.com/news/3334851-live-nation-reaps-heavy-revenue-gains-q4-guides-2018-growth\" target=\"_blank\">earnings report yesterday</a> showed increasing operating loss on concerts and a loss in ticketing -- may be taking another hit if the Dallas Cowboys switch their ticketing deal to SeatGeek.</li>    <li>An earlier report in the <i>Dallas Business Journal</i> says the Cowboys will <a href=\"https://www.bizjournals.com/dallas/news/2018/02/28/sources-cowboys-shifting-deal-from-ticketmaster-to.html\" target=\"_blank\">join the New Orleans Saints on SeatGeek</a>, a move that flies in the face of the NFL's master ticketing deals with Live Nation's Ticketmaster and StubHub covering the next five years, as well as Legends Hospitality (part-owned by the Cowboys) and its partnership with Live Nation.</li>    <li>The Cowboys are expected to get an equity stake of about 15% in SeatGeek, according to the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335257\" data-linked=\"Reported Dallas Cowboys ticketing move may ding Live Nation\" data-tweet=\"$LYV - Reported Dallas Cowboys ticketing move may ding Live Nation https://seekingalpha.com/news/3335257-reported-dallas-cowboys-ticketing-move-may-ding-live-nation?source=tweet\" data-url=\"https://seekingalpha.com/news/3335257-reported-dallas-cowboys-ticketing-move-may-ding-live-nation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335256\" data-ts=\"1519847625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELL\" target=\"_blank\">DELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335256-deutsche-bank-initiates-dell-57-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank initiates Dell at 57% upside</a></h4><ul><li>        Deutsche Bank initiates Dell Technologies (DVMT) at Buy with a $114 price target, a 57% upside to yesterday&rsquo;s close.</li><li>               Firm says Dell is a complex security that makes for more than a cheap way to get VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) exposure. &nbsp;&nbsp;</li><li>               Dell&rsquo;s uncertainty grew in January when strategic option discussions drove shares down 21% and widened the discount to VMware shares to a new high of 45%.&nbsp;</li><li>               Deutsche Bank initiates coverage ahead of the Q4 reports scheduled for tomorrow (VMware) and March 8 (Dell).&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Dell shares are&nbsp;<font color='green'>up 2.7%</font>&nbsp;to $74.70 with a 52-week range of $59.93 to $92.40.&nbsp;</li><li>               VMware shares are&nbsp;<font color='green'>up 3.2%</font>&nbsp;to $133.13 with a 52-week range of $85.45 to $165.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3327745-dell-getting-serious-vmware-options\" target=\"_blank\">Dell getting serious about VMware options</a> (Feb. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335256\" data-linked=\"Deutsche Bank initiates Dell at 57% upside\" data-tweet=\"$DELL $DELL $VMW - Deutsche Bank initiates Dell at 57% upside https://seekingalpha.com/news/3335256-deutsche-bank-initiates-dell-57-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3335256-deutsche-bank-initiates-dell-57-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335250\" data-ts=\"1519846008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335250-judge-explains-order-halting-energy-transfers-bayou-pipeline-construction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Judge explains order halting Energy Transfer&#39;s Bayou pipeline construction</a></h4><ul>     <li>The U.S. district judge who stopped construction of Energy Transfer Partners' (ETP <font color='red'>-2%</font>) Bayou Bridge oil pipeline through a Louisiana swamp concluded that the project's <a href=\"https://finance.yahoo.com/m/d551f9fd-a5ca-3796-bd01-e5cae6ce175e/ss_judge-explains-order-halting.html\" target=\"_blank\">irreversible environmental damage outweighs</a> the economic harm that a delay brings to the company building it.</li>     <li>In a 61-page ruling explaining her decision <a href=\"https://seekingalpha.com/news/3333992-permit-revoked-energy-transfers-bayou-pipeline\" target=\"_blank\">last week</a> to stop construction of the pipeline in the Atchafalaya Basin, the judge says the project potentially threatens the hydrology of the basin and \"poses the threat of destruction of already diminishing wetlands.\"</li>     <li>The preliminary injunction only applies to the basin and does not prevent ETP from working elsewhere along the pipeline's 162-mile-long path from Lake Charles to St. James Parish.</li>     <li>The company early this week asked the judge to suspend her order while it appeals but she refused, and it is asking the 5th U.S. Circuit Court of Appeals to review the decision.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335250\" data-linked=\"Judge explains order halting Energy Transfer&#39;s Bayou pipeline construction\" data-tweet=\"$ET - Judge explains order halting Energy Transfer&#39;s Bayou pipeline construction https://seekingalpha.com/news/3335250-judge-explains-order-halting-energy-transfers-bayou-pipeline-construction?source=tweet\" data-url=\"https://seekingalpha.com/news/3335250-judge-explains-order-halting-energy-transfers-bayou-pipeline-construction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>157&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335249\" data-ts=\"1519845491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335249-fda-oks-sorrentos-ztlido-for-phn-related-pain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Sorrento&#39;s ZTlido for PHN-related pain</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17088031-sorrento-therapeutics-subsidiary-scilex-receives-us-fda-approval-non-opioid-ztlido-lidocaine\" target=\"_blank\">approves </a>Sorrento Therapeutics' (<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+0.6%</font>) ZTlido (lidocaine topical system) 1.8% for the relief of pain associated with post-herpetic neuralgia &#40;PHN&#41;.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294799-fda-accepts-sorrentos-resubmitted-marketing-application-ztlido-action-date-february-28-2018\" target=\"_blank\">FDA accepts Sorrento's resubmitted marketing application for ZTlido, action date February 28, 2018</a> (Sept. 12, 2017)</li><li>Shares are up&nbsp;<font color='green'>4%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335249\" data-linked=\"FDA OKs Sorrento&#39;s ZTlido for PHN-related pain\" data-tweet=\"$SRNE - FDA OKs Sorrento&#39;s ZTlido for PHN-related pain https://seekingalpha.com/news/3335249-fda-oks-sorrentos-ztlido-for-phn-related-pain?source=tweet\" data-url=\"https://seekingalpha.com/news/3335249-fda-oks-sorrentos-ztlido-for-phn-related-pain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335243\" data-ts=\"1519844598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSPP\" target=\"_blank\">RSPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335243-energy-materials-top-gainers-losers-of-2-00-pm-2-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/28/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RSPP' title='RSP Permian'>RSPP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/UNVR' title='Univar'>UNVR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FI' title='Frank&#39;s International'>FI</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335243\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/28/2018)\" data-tweet=\"$RSPP $RSPP $UNVR - Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/28/2018) https://seekingalpha.com/news/3335243-energy-materials-top-gainers-losers-of-2-00-pm-2-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3335243-energy-materials-top-gainers-losers-of-2-00-pm-2-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335232\" data-ts=\"1519844250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335232-bank-of-america-fires-two-for-sexual-misconduct\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of America fires two more for sexual-misconduct</a></h4><ul><li>Both discharged employees are from the prime-brokerage unit. They were let go for interfering in an investigation into sexual-misconduct by the unit's former head Omeed Malik, <a href=\"https://www.wsj.com/articles/sexual-misconduct-probe-inside-bank-of-america-widens-with-new-firings-1519838019\" target=\"_blank\">who was fired back in January.</a></li><li>\"Mr. Malik was discharged for personal conduct in violation of firm standards, including interfering with the firm&rsquo;s review of the matter,&rdquo; said Bank of America in a regulatory filing.</li><li><a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='green'>+0.8%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3335232\" data-linked=\"Bank of America fires two more for sexual-misconduct\" data-tweet=\"$BAC - Bank of America fires two more for sexual-misconduct https://seekingalpha.com/news/3335232-bank-of-america-fires-two-for-sexual-misconduct?source=tweet\" data-url=\"https://seekingalpha.com/news/3335232-bank-of-america-fires-two-for-sexual-misconduct\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335240\" data-ts=\"1519844066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335240-dicks-higher-after-firearms-decision-seen-strategic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dick&#39;s higher after firearms decision seen as strategic</a></h4><ul> <li>Bloomberg Intelligence thinks the assault-rifle ban by Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='green'>+1.1%</font>) has some positive benefits from a shareholder perspective.</li> <li>The decision could lead to more buying from large institutional investors that typically avoid holding shares of assault-rifle sellers, notes BI's Chen Grazutis.</li> <li>Other analysts have pointed today to the likelihood that Dick's brand popularity with younger consumers will improve.</li> <li>Dick's is out in front of broad market averages for the day with a&nbsp;<font color='green'>1.15% gain</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335240\" data-linked=\"Dick&#39;s higher after firearms decision seen as strategic\" data-tweet=\"$DKS - Dick&#39;s higher after firearms decision seen as strategic https://seekingalpha.com/news/3335240-dicks-higher-after-firearms-decision-seen-strategic?source=tweet\" data-url=\"https://seekingalpha.com/news/3335240-dicks-higher-after-firearms-decision-seen-strategic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335239\" data-ts=\"1519843849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335239-maxim-turns-bearish-on-mannkind-cuts-to-sell-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim turns bearish on MannKind, cuts to Sell; shares down 6%</a></h4><ul><li>For what it's worth, Maxim Group has downgraded MannKind (<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-5.5%</font>) to Sell with a $1 (67% downside risk) price target. Analyst Jason Kolbert says the company failed to get much of a sales bump from its TV campaign for Afrezza on the Dr. Phil and Ellen DeGeneres shows. More capital will be needed, likely on unfavorable terms.</li><li>Uber bull H.C. Wainwright, however, remains undeterred with a Buy rating.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3335239\" data-linked=\"Maxim turns bearish on MannKind, cuts to Sell; shares down 6%\" data-tweet=\"$MNKD - Maxim turns bearish on MannKind, cuts to Sell; shares down 6% https://seekingalpha.com/news/3335239-maxim-turns-bearish-on-mannkind-cuts-to-sell-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3335239-maxim-turns-bearish-on-mannkind-cuts-to-sell-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335237\" data-ts=\"1519843523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIVO\" target=\"_blank\">TIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335237-jpmorgan-tivo-heavy-upside-in-case-of-leveraged-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan: TiVo has heavy upside in case of leveraged buyout</a></h4><ul>   <li>TiVo (NASDAQ:<a href='https://seekingalpha.com/symbol/TIVO' title='TiVo Inc.'>TIVO</a>) is <font color='green'>up 12%</font> and has tagged its highest point since mid-December after yesterday's earnings report featured an announcement that it's <a href=\"https://seekingalpha.com/news/3334836-tivo-plus-11_8-percent-starts-examine-strategic-alternatives\" target=\"_blank\">looking at strategic alternatives</a>.</li>    <li>TiVo's hired LionTree Advisors, suggesting M&amp;A activity on the horizon.</li>    <li>JPMorgan took the opportunity to reiterate its stance that the company could be worth in the mid-$20 range in a leveraged buyout. Shares are currently at $15.15.</li>    <li>The firm's Sterling Auty updated his price target to $30, which includes $7/share in value from resolving Comcast as a customer, and implies nearly 100% upside. (h/t Bloomberg)</li>    <li><a href=\"https://seekingalpha.com/article/4151504-tivos-tivo-ceo-enrique-rodriguez-q4-2017-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3335237\" data-linked=\"JPMorgan: TiVo has heavy upside in case of leveraged buyout\" data-tweet=\"$TIVO - JPMorgan: TiVo has heavy upside in case of leveraged buyout https://seekingalpha.com/news/3335237-jpmorgan-tivo-heavy-upside-in-case-of-leveraged-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3335237-jpmorgan-tivo-heavy-upside-in-case-of-leveraged-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335233\" data-ts=\"1519842728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGS\" target=\"_blank\">BGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335233-b-and-g-foods-falls-to-52-week-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B&amp;G Foods falls to 52-week low</a></h4><ul> <li>B&amp;G Foods (<a href='https://seekingalpha.com/symbol/BGS' title='B&G Foods, Inc.'>BGS</a> <font color='red'>-10%</font>) slides to a 52-week low after Q4 revenue falls short and full-year guidance is set below expectations.</li> <li>The company sees FY18 revenue of $474M vs. $482M consensus and FY18 EPS of $2.05-$2.25 vs. $2.26 consensus.</li> <li>B&amp;G execs delved into inflation pressures during the company's earnings call (transcript), including mentioning higher-than-anticipated freight transportation and warehouse costs.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3335233\" data-linked=\"B&amp;G Foods falls to 52-week low\" data-tweet=\"$BGS - B&amp;G Foods falls to 52-week low https://seekingalpha.com/news/3335233-b-and-g-foods-falls-to-52-week-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3335233-b-and-g-foods-falls-to-52-week-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335206\" data-ts=\"1519842221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRZBF\" target=\"_blank\">CRZBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335206-goldman-and-socgen-looking-to-buy-commerzbanks-etf-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman and SocGen looking to buy Commerzbank&#39;s ETF business</a></h4><div><ul><li>Commerzbank (<a href='https://seekingalpha.com/symbol/CRZBF' title='Commerzbank AG'>OTCPK:CRZBF</a> <font color='green'>+0.5%</font>)&nbsp;put the unit up for sale last year as it scales back trading and focuses on lending,&nbsp;<a href=\"https://www.bloomberg.com/news/articles/2018-02-28/goldman-sachs-socgen-said-to-submit-bids-for-commerzbank-unit\" target=\"_blank\">according to Bloomberg</a>.</li><li>Both Goldman (<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a>&nbsp;<font color='red'>-0.4%</font>) and SocGen (<a href='https://seekingalpha.com/symbol/SCGLY' title='Societe Generale ADR'>OTCPK:SCGLY</a>&nbsp;<font color='green'>+1.1%</font>) have submitted final bids, and are more interested in just the ETF business, but Commerzbank wants the buyer to acquire all of its trading operations.</li><li>The business generated&nbsp;&euro;381M in revenue in 2017 and was the only unit in the bank's corporate side to see incomes rise.</li></ul><div>&nbsp;</div></div><div class=\"tiny-share-widget\" data-id=\"3335206\" data-linked=\"Goldman and SocGen looking to buy Commerzbank&#39;s ETF business\" data-tweet=\"$CRZBF $CRZBF $GS - Goldman and SocGen looking to buy Commerzbank&#39;s ETF business https://seekingalpha.com/news/3335206-goldman-and-socgen-looking-to-buy-commerzbanks-etf-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3335206-goldman-and-socgen-looking-to-buy-commerzbanks-etf-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335227\" data-ts=\"1519841976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSP\" target=\"_blank\">SSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335227-scrippsminus-5_3-profits-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scripps -5.3% as profits dip</a></h4><ul>   <li>E.W. Scripps (NASDAQ:<a href='https://seekingalpha.com/symbol/SSP' title='The E.W. Scripps Company'>SSP</a>) is <font color='red'>off 5.3%</font> after missed revenue expectations in <a href=\"https://seekingalpha.com/news/3335037-e-w-scripps-beats-0_11-misses-revenue\" target=\"_blank\">Q4 earnings</a> (and while trading ex-dividend today).</li>    <li>A boost in revenues from national media (fueled by a Katz acquisition) more than made up for a decline in its core local media segment. Revenues rose 1.6% overall.</li>    <li>Meanwhile costs for segments, shared services and corporate were up 29% to $222M, driven by the new expenses at Katz and higher network programming fees.</li>    <li>Net income fell to $11.5M from $36.3M; the current quarter includes a gain on Katz investment of $5.4M.</li>    <li>Political revenues fell $52.8M due to a non-election year.</li>    <li>Revenue by segment (after segment reorg): Local media, $202.6M (down 16.5%); National media, $52.97M (up 486.4%); Other, $1.4M (up 11.7%).</li>    <li>For Q1, it's guiding to local media revenue up mid-single digits and retransmission revenue up about 10%, along with national media revenue in the mid- to high-$50M range. It's forecasting capex in the high-single digit millions.</li>    <li><a href=\"https://seekingalpha.com/pr/17087202-scripps-reports-fourth-quarter-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3335227\" data-linked=\"Scripps -5.3% as profits dip\" data-tweet=\"$SSP - Scripps -5.3% as profits dip https://seekingalpha.com/news/3335227-scrippsminus-5_3-profits-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3335227-scrippsminus-5_3-profits-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335224\" data-ts=\"1519841404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGFV\" target=\"_blank\">BGFV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335224-big-five-sporting-goods-recovers-from-early-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big Five Sporting Goods recovers from early decline</a></h4><ul> <li>Big Five Sportings Goods (<a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='green'>+4.2%</font>) tracks higher after initially being down as much as 4%.</li> <li>The company posted in-line Q4 results yesterday during a quarter in which same-store sales fell 9.4%.</li> <li>\"Our performance was impacted by an extraordinarily challenging December period as a result of extremely unfavorable winter weather conditions in most of our markets,\" said CEO Steven Miller.</li> <li>It's unclear if the turnaround in share price today on Big Five is directly attributable to the decision by Dick's to stop selling assault-style rifles.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334736-big-5-sporting-goods-eps-line-misses-revenue\" target=\"_blank\">Big 5 Sporting Goods EPS in-line, misses on revenue</a> (Feb. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335224\" data-linked=\"Big Five Sporting Goods recovers from early decline\" data-tweet=\"$BGFV - Big Five Sporting Goods recovers from early decline https://seekingalpha.com/news/3335224-big-five-sporting-goods-recovers-from-early-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3335224-big-five-sporting-goods-recovers-from-early-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335222\" data-ts=\"1519840712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHH\" target=\"_blank\">PHH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335222-financials-top-5-gainers-losers-of-1-00-pm-02-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (02/28/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PHH' title='PHH Corporation'>PHH</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/NNI' title='Nelnet, Inc.'>NNI</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LGIH' title='LGI Homes, Inc.'>LGIH</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SRG' title='Seritage Growth Properties'>SRG</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335222\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (02/28/2018)\" data-tweet=\"$PHH $PHH $NNI - Financials - Top 5 Gainers / Losers as of 1:00 PM (02/28/2018) https://seekingalpha.com/news/3335222-financials-top-5-gainers-losers-of-1-00-pm-02-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3335222-financials-top-5-gainers-losers-of-1-00-pm-02-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335221\" data-ts=\"1519840695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335221-hertz-down-nearly-5-after-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz down nearly 5% after results</a></h4><ul><li>Q4's adjusted net loss of $64M or $0.77 per share was wider than $59M and $0.71 a year ago, and worse than estimates for a loss of just $0.60.</li><li>Full-year adjusted net loss of $1.59 per share vs. net income of $0.49 per share in 2016.</li><li>\"A more competitive earnings profile,\" isn't expected until 2019, says CEO Kathryn Marinello in the earnings press release. \"Opaque promises of a better tomorrow aren&rsquo;t likely going to be comforting,\" says Bloomberg's Joel Levington.</li><li><a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>&nbsp;<font color='red'>-4.6%</font>, but well off the day's worst levels.</li><li><a href=\"https://seekingalpha.com/article/4151693-hertz-global-holdings-inc-2017-q4-results-earnings-call-slides\" target=\"_blank\">Earnings call presentation slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3334845-hertz-global-holdings-misses-0_17-beats-revenue\" target=\"_blank\">Hertz Global Holdings misses by $0.17, beats on revenue</a> (Feb. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335221\" data-linked=\"Hertz down nearly 5% after results\" data-tweet=\"$HTZ - Hertz down nearly 5% after results https://seekingalpha.com/news/3335221-hertz-down-nearly-5-after-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3335221-hertz-down-nearly-5-after-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335219\" data-ts=\"1519840415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335219-midday-gainers-losers-2-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (2/28/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/AAXN' title='Axon Enterprise, Inc.'>AAXN</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/PHH' title='PHH Corporation'>PHH</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/STB' title='Student Transportation Inc'>STB</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/LINC' title='Lincoln Educational Services Corporation'>LINC</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/APEI' title='American Public Education, Inc.'>APEI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a> <font color='green'>+18%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ROG' title='Rogers Corporation'>ROG</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/HURN' title='Huron Consulting Group Inc.'>HURN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335219\" data-linked=\"Midday Gainers / Losers (2/28/2018)\" data-tweet=\"$ECYT $ECYT $AAXN - Midday Gainers / Losers (2/28/2018) https://seekingalpha.com/news/3335219-midday-gainers-losers-2-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3335219-midday-gainers-losers-2-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335215\" data-ts=\"1519840083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDC\" target=\"_blank\">RDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335215-rowanminus-4-following-mixed-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rowan -4% following mixed Q4 results</a></h4><ul>     <li>Rowan Companies (<a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color='red'>-4.3%</font>) is lower after reporting a sizeable <a href=\"https://seekingalpha.com/news/3334984-rowan-misses-0_01-beats-revenue\" target=\"_blank\">Q4 loss</a> and a 15% Y/Y decline in revenues to $296M, which nevertheless was ahead of analyst expectations.</li>     <li>RDC's Q4 net income of $112M, compared to a $24M net loss in the year-ago quarter, included a $152M gain on the sale of three rigs to ARO Drilling, the company's 50-50 joint venture with Saudi Aramco; RDC plans to contribute two more rigs to the JV by year-end 2018.</li>     <li>RDC's fleet utilization in Q4 was&nbsp;70% vs. 65% in the prior-year quarter, with utilization of the deepwater part of the fleet plunging to 34% from&nbsp;75% a year ago and jack-up fleet utilization rising to 77% from&nbsp;63%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335215\" data-linked=\"Rowan -4% following mixed Q4 results\" data-tweet=\"$RDC - Rowan -4% following mixed Q4 results https://seekingalpha.com/news/3335215-rowanminus-4-following-mixed-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3335215-rowanminus-4-following-mixed-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335214\" data-ts=\"1519839829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335214-analyst-ups-workday-target-to-13-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst ups Workday target to 13% upside</a></h4><ul><li>        Canaccord Genuity maintains a Buy rating and raises its Workday (NYSE:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a>) price target from $125 to $145 (13% upside to yesterday&rsquo;s close) following the earnings report.</li><li>               Firm says report showed &ldquo;business momentum is accelerating at least a bit&rdquo; and while it won&rsquo;t say Workday is on sale, does believe investors should pick up at least a starter position. &nbsp;&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Workday shares are&nbsp;<font color='red'>down 1.2%</font>&nbsp;to $126.63 with a 52-week range of $80.61 to $131.18.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334787-workday-minus-0_8-percent-despite-q4-beats-34-percent-subscription-growth-guidance-call\" target=\"_blank\">Workday -0.8% despite Q4 beats, 34% subscription growth; guidance on call</a> (Feb. 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335052-earnings-call-workday-provides-upside-revenue-guidance\" target=\"_blank\">Earnings call: Workday provides upside revenue guidance</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335214\" data-linked=\"Analyst ups Workday target to 13% upside\" data-tweet=\"$WDAY - Analyst ups Workday target to 13% upside https://seekingalpha.com/news/3335214-analyst-ups-workday-target-to-13-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3335214-analyst-ups-workday-target-to-13-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335211\" data-ts=\"1519839645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335211-investors-clamor-for-telegram-ico\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors clamor for Telegram ICO</a></h4><ul><li>The much-anticipated ICO for Telegram raised $850M in its first round, <a href=\"https://www.bloomberg.com/news/articles/2018-02-28/telegram-said-to-triple-price-in-largest-initial-coin-offering\" target=\"_blank\">according to Bloomberg's sources</a>, and the company is more than tripling the price for a new round expected to close early next month.</li><li>The tokens are called Grams and were initially offered to larger investors for $0.37 each. They're now being offered at $1.33.</li><li>In total, the two stages are hoped to raise $1.7B, and another sale (seen priced at $2.40 each) could bring that amount to more than $2.5B.</li><li>Telegram founder Pavel Durov previously started Russian social network VK.com.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335211\" data-linked=\"Investors clamor for Telegram ICO\" data-tweet=\"$GBTC $GBTC $COIN - Investors clamor for Telegram ICO https://seekingalpha.com/news/3335211-investors-clamor-for-telegram-ico?source=tweet\" data-url=\"https://seekingalpha.com/news/3335211-investors-clamor-for-telegram-ico\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335205\" data-ts=\"1519839129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335205-sell-siders-weigh-in-after-valeants-q4-miss-and-soft-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-siders weigh in after Valeant&#39;s Q4 miss and soft guidance</a></h4><ul><li>Valeant Pharmaceuticals (VRX <font color='red'>-11%</font>) is down on almost double normal volume after releasing Q4 and 2017 results this morning. Analysts' take:</li><li>Mizuho's Irina Koffler (UNDERPERFORM/$10): puzzled over quarter/quarter declines in key business segments when the rest of the sector is typically strongest.</li><li>Cowen's Louise Chen (OVERWEIGHT/$25): turnaround story underappreciated, today's selling overdone. Sees 2018 as a \"trough\" year. Dermatology business could double by 2022 led by three potential product approvals this year.</li><li>Barclays' Doug Tsao (EQUAL WEIGHT/$20): 2018 guidance largely in line with his model. Says most of the Street not accounting for the anticipated loss of exclusivity headwinds across the company's portfolio.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3335205\" data-linked=\"Sell-siders weigh in after Valeant&#39;s Q4 miss and soft guidance\" data-tweet=\"$BHC - Sell-siders weigh in after Valeant&#39;s Q4 miss and soft guidance https://seekingalpha.com/news/3335205-sell-siders-weigh-in-after-valeants-q4-miss-and-soft-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3335205-sell-siders-weigh-in-after-valeants-q4-miss-and-soft-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335207\" data-ts=\"1519838342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335207-ackman-out-of-herbalife-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ackman out of Herbalife - CNBC</a></h4><ul><li>CNBC <a href=\"https://www.cnbc.com/2018/02/28/ackman-exits-bet-against-herbalife.html\" target=\"_blank\">reports </a>that short seller Bill Ackman has exited from his much-publicized short bet on Herbalife (<a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a> <font color='green'>+6.6%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3306725-ackman-closes-short-stock-position-herbalife-put-options-limit-capital-risk-3-percent\" target=\"_blank\">Ackman closes short stock position in Herbalife, put options to limit capital risk to 3%</a> (Nov. 1, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335207\" data-linked=\"Ackman out of Herbalife - CNBC\" data-tweet=\"$HLF - Ackman out of Herbalife - CNBC https://seekingalpha.com/news/3335207-ackman-out-of-herbalife-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3335207-ackman-out-of-herbalife-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335204\" data-ts=\"1519838108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUSK\" target=\"_blank\">TUSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335204-mammoth-energy-hits-record-high-on-500m-puerto-rico-contract-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mammoth Energy hits record high on $500M Puerto Rico contract increase</a></h4><ul>     <li>Mammoth Energy Services (<a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='green'>+7.7%</font>) surges to all-time highs on news its Cobra Acquisitions subsidiary <a href=\"https://seekingalpha.com/pr/17087063-cobra-s-puerto-rico-contract-increased-approximately-945-million\" target=\"_blank\">increased its existing contract</a> to assist in the restoration of Puerto Rico's electric infrastructure to $945M from $445M.</li>     <li>In addition to continuing with its repair and restoration work, Cobra will be able to source construction materials needed to rebuild the island's electrical infrastructure on a pass through basis.</li>     <li>In the past, Cobra relied on third party  contractors, hired by the Puerto Rico Electric Power Authority, and the U.S. Army Corps of Engineers to supply all materials.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335204\" data-linked=\"Mammoth Energy hits record high on $500M Puerto Rico contract increase\" data-tweet=\"$TUSK - Mammoth Energy hits record high on $500M Puerto Rico contract increase https://seekingalpha.com/news/3335204-mammoth-energy-hits-record-high-on-500m-puerto-rico-contract-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3335204-mammoth-energy-hits-record-high-on-500m-puerto-rico-contract-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335202\" data-ts=\"1519837882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTX\" target=\"_blank\">UTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335202-ackman-reportedly-mystery-investor-in-utx\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ackman reportedly the mystery investor in UTX</a></h4><ul><li>CNBC earlier <a href=\"https://seekingalpha.com/news/3335163-utx-higher-activist-takes-position\" target=\"_blank\">this morning reported</a> a \"well known\" activist as having taken a stake in United Technologies (NYSE:<a href='https://seekingalpha.com/symbol/UTX' title='United Technologies Corporation'>UTX</a>). They're now reporting <a href=\"https://twitter.com/CNBCnow/status/968893279801659393\" target=\"_blank\">that investor as</a> Bill Ackman.</li><li>Shares remain&nbsp;<font color='green'>higher by about 2%</font>.</li><li>Merger partner Rockwell Collins (<a href='https://seekingalpha.com/symbol/COL' title='Rockwell Collins, Inc.'>COL</a> <font color='green'>+0.9%</font>) is active as well.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335202\" data-linked=\"Ackman reportedly the mystery investor in UTX\" data-tweet=\"$UTX $UTX $COL - Ackman reportedly the mystery investor in UTX https://seekingalpha.com/news/3335202-ackman-reportedly-mystery-investor-in-utx?source=tweet\" data-url=\"https://seekingalpha.com/news/3335202-ackman-reportedly-mystery-investor-in-utx\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335188\" data-ts=\"1519837823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBP\" target=\"_blank\">IBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335188-homebuilders-down-4th-quarter-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homebuilders down as 4th quarter earnings miss</a></h4><div><ul><li>Installed Building Products (<a href='https://seekingalpha.com/symbol/IBP' title='Installed Building Products, Inc.'>IBP</a> <font color='red'>-10.4%</font>) fell as much as much as&nbsp;<font color='red'>21%</font>&nbsp;earlier as earnings missed estimates.</li><li>This comes after LGI Homes (<a href='https://seekingalpha.com/symbol/LGIH' title='LGI Homes, Inc.'>LGIH</a> <font color='red'>-9.1%</font>) is down&nbsp;<font color='red'>14%&nbsp;</font>since<font color='red'>&nbsp;</font>its earnings announcement yesterday, which beat estimates,&nbsp;but the company's margin outlook&nbsp;for 2018 came in weak.</li><li>It may be tough for builders to outperform, and the recent weakness is likely due to rising interest rates notes MKM analyst Megan McGrath.</li><li>Source: Bloomberg</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>, <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>, <a href='https://seekingalpha.com/symbol/PKB' title='Invesco Dynamic Building & Construction Portfolio ETF'>PKB</a>, <a href='https://seekingalpha.com/symbol/NAIL' title='Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF'>NAIL</a>, <a href='https://seekingalpha.com/symbol/HOML' title='ETRACS Monthly Reset 2xLeveraged ISE Exclusively Homebuilders ETN'>HOML</a>, <a href='https://seekingalpha.com/symbol/CLAW' title='Direxion Daily Homebuilders & Supplies Bear 3x Shares ETF'>CLAW</a></li></ul> &nbsp;</div><div class=\"tiny-share-widget\" data-id=\"3335188\" data-linked=\"Homebuilders down as 4th quarter earnings miss\" data-tweet=\"$IBP $IBP $LGIH - Homebuilders down as 4th quarter earnings miss https://seekingalpha.com/news/3335188-homebuilders-down-4th-quarter-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3335188-homebuilders-down-4th-quarter-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335199\" data-ts=\"1519837719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335199-northeast-health-plan-to-cover-egalets-arymo-er-and-sprix-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northeast health plan to cover Egalet&#39;s ARYMO ER and SPRIX ; shares up 3%</a></h4><ul><li>Egalet (<a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='green'>+2.5%</font>) is up, albeit on lower-than-normal volume, on the heels of is <a href=\"https://seekingalpha.com/pr/17087066-egalet-announces-large-regional-health-plan-placed-arymo-er-sprix-nasal-spray-preferred\" target=\"_blank\">announcement </a>that an unnamed Northeastern U.S. regional health plan has added pain meds <a href=\"https://www.arymoer.com/\" target=\"_blank\">ARYMO ER</a> (morphine sulfate) extended-release tablets and <a href=\"https://www.sprix.com/patient/about-sprix/\" target=\"_blank\">SPRIX </a>(ketorolac tromethamine) Nasal Spray to its preferred formulary effective immediately.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335199\" data-linked=\"Northeast health plan to cover Egalet&#39;s ARYMO ER and SPRIX ; shares up 3%\" data-tweet=\"$EGLT $ZCOR - Northeast health plan to cover Egalet&#39;s ARYMO ER and SPRIX ; shares up 3% https://seekingalpha.com/news/3335199-northeast-health-plan-to-cover-egalets-arymo-er-and-sprix-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3335199-northeast-health-plan-to-cover-egalets-arymo-er-and-sprix-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335194\" data-ts=\"1519837277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEWM\" target=\"_blank\">NEWM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335194-new-mediaplus-8_3-revenues-profits-jump-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Media +8.3% as revenues, profits jump in Q4</a></h4><ul>   <li>New Media Investment Group (NYSE:<a href='https://seekingalpha.com/symbol/NEWM' title='New Media'>NEWM</a>) is <font color='green'>up 8.3%</font> after <a href=\"https://seekingalpha.com/news/3334987-new-media-beats-0_18-beats-revenue\" target=\"_blank\">Q4 earnings</a> showed an acquisition-fueled 18% jump in revenues and and 82% gain in profits.</li>    <li>Revenues fell 5.6% on an organic same-store basis, though that improved 80 basis points from Q3.</li>    <li>As-adjusted EBITDA rose to $58.98M from $49.7M. Operating income came to $32.4M, while net income was $26.4M, up from $14.5M.</li>    <li>Revenue breakout: Advertising, $201.6M (up 10.5%); Circulation, $140.2M (up 28.8%); Commercial printing and other, $52.7M (up 24.5%).</li>    <li>Liquidity (including cash and undrawn revolver) was $82.6M at year-end.</li>    <li><a href=\"https://seekingalpha.com/article/4151713-new-media-2018-q4-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li>    <li><a href=\"https://seekingalpha.com/pr/17087102-new-media-announces-strong-fourth-quarter-and-full-year-2017-results-dividend-0_37-per-common\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3335194\" data-linked=\"New Media +8.3% as revenues, profits jump in Q4\" data-tweet=\"$NEWM - New Media +8.3% as revenues, profits jump in Q4 https://seekingalpha.com/news/3335194-new-mediaplus-8_3-revenues-profits-jump-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3335194-new-mediaplus-8_3-revenues-profits-jump-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335192\" data-ts=\"1519837237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEQU\" target=\"_blank\">KEQU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335192-consumer-top-gainers-losers-of-12-00-pm-2-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (2/28/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KEQU' title='Kewaunee Scientific Corporation'>KEQU</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BGS' title='B&G Foods, Inc.'>BGS</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335192\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (2/28/2018)\" data-tweet=\"$KEQU $KEQU $HLF - Consumer - Top Gainers / Losers as of 12:00 pm (2/28/2018) https://seekingalpha.com/news/3335192-consumer-top-gainers-losers-of-12-00-pm-2-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3335192-consumer-top-gainers-losers-of-12-00-pm-2-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335190\" data-ts=\"1519837116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335190-sangamo-on-go-to-expand-study-of-sb-fix-in-hemophilia-b-in-europe-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo on go to expand study of SB-FIX in hemophilia B in Europe; shares up 3%</a></h4><ul><li>UK regulators have <a href=\"https://seekingalpha.com/pr/17087201-sangamo-announces-u-k-authorization-clinical-trial-evaluating-zinc-finger-nuclease-vivo\" target=\"_blank\">signed off </a>on a Phase 1/2 clinical trial assessing Sangamo Therapeutics' (<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+2.6%</font>) SB-FIX, a zinc finger nuclease &#40;ZFN&#41;-mediated gene editing treatment, in patients with hemophilia B, the first <em>in vivo</em> genome editing study in Europe. Recruitment is already underway in the U.S.</li><li>The company says it plans to file new applications in the UK for studies of gene-editing therapies SB-318 and SB-913, in mucopolysaccharidosis Type I and Type II, respectively, later this year.</li><li>ZFN is a gene editing technology that uses a DNA-cutting enzyme attached to zinc finger DNA-binding proteins to recognize and edit specific sequences of DNA.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335190\" data-linked=\"Sangamo on go to expand study of SB-FIX in hemophilia B in Europe; shares up 3%\" data-tweet=\"$SGMO - Sangamo on go to expand study of SB-FIX in hemophilia B in Europe; shares up 3% https://seekingalpha.com/news/3335190-sangamo-on-go-to-expand-study-of-sb-fix-in-hemophilia-b-in-europe-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3335190-sangamo-on-go-to-expand-study-of-sb-fix-in-hemophilia-b-in-europe-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335187\" data-ts=\"1519836324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMMDF\" target=\"_blank\">CMMDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335187-cannimed-launches-cannabis-topical-cream-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CanniMed launches cannabis topical cream; shares up 5%</a></h4><ul><li>CanniMed (<a href='https://seekingalpha.com/symbol/CMMDF' title='Cannimed Therapeutics Inc.'>OTC:CMMDF</a> <font color='green'>+5.2%</font>) <a href=\"https://seekingalpha.com/pr/17087107-cannimed-medical-cannabis-topical-cream-provides-fast-acting-relief-patients-need\" target=\"_blank\">announces </a>that it is shipping its CanniMed Topical Cream Kits to registered patients for the potential treatment of inflammation, neuropathic pain and allergic skin conditions.</li><li>The kits contains a bottle of cannabis oil that the user mixes with a base gel before applying. The combination retails for as low as $143.99.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335187\" data-linked=\"CanniMed launches cannabis topical cream; shares up 5%\" data-tweet=\"$CMMDF - CanniMed launches cannabis topical cream; shares up 5% https://seekingalpha.com/news/3335187-cannimed-launches-cannabis-topical-cream-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3335187-cannimed-launches-cannabis-topical-cream-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335172\" data-ts=\"1519835734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335172-banks-are-pushing-for-significant-loosening-of-volcker-rule\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Banks are pushing for significant loosening of the Volcker Rule</a></h4><ul><li><a href=\"https://www.cnbc.com/2018/02/28/us-regulators-examine-wall-streets-volcker-rule-wish-list-sources.html\" target=\"_blank\">Regulators are examining</a>&nbsp;potential changes that can be made to the legislation which bans proprietary trading using the bank&rsquo;s own capital.</li><li>Banks under $10B in assets are likely to get relief as part of a new bill being considered in Congress.</li><li>Larger banks also want reprieve as they would like to shift the monitoring of violations of the Volcker Rule to regulators.</li><li>Currently trades held for less than 60 days need an explanation convincing regulators the trades are client activity.</li><li>Related Tickers: <a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a>, <a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a>, <a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a>, <a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a>, <a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a>, <a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a>,&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IAT' title='iShares U.S. Regional Banks ETF'>IAT</a>, <a href='https://seekingalpha.com/symbol/KIE' title='SPDR S&P Insurance ETF'>KIE</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3335172\" data-linked=\"Banks are pushing for significant loosening of the Volcker Rule\" data-tweet=\"$JPM $JPM $BAC - Banks are pushing for significant loosening of the Volcker Rule https://seekingalpha.com/news/3335172-banks-are-pushing-for-significant-loosening-of-volcker-rule?source=tweet\" data-url=\"https://seekingalpha.com/news/3335172-banks-are-pushing-for-significant-loosening-of-volcker-rule\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335183\" data-ts=\"1519835623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNH\" target=\"_blank\">SYNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335183-syneos-q4-top-line-up-165-non-gaap-earnings-up-66-shares-up-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syneos Q4 top line up 165%; non-GAAP earnings up 66%; shares up 18%</a></h4><ul><li>Syneos Health (<a href='https://seekingalpha.com/symbol/SYNH' title='Syneos Health, Inc.'>SYNH</a> <font color='green'>+17.5%</font>) <a href=\"https://seekingalpha.com/pr/17087094-syneos-health-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4 results</a> ($M): Total revenues: 1,076.7 (+165.1%); net service revenue: 750.5 (+185.4%).</li><li>Net income: (15.0) (-140.0%); non-GAAP net income: 74.1 (+65.8%); EPS: (0.14) (-120.6%); non-GAAP EPS: 0.70 (+62.8%); cash flow ops (full-year): 198.3 (+81.4%).</li><li><strong>2018 guidance</strong>: net service revenue: $3,229.5 - 3,334.5; non-GAAP net income: $285.5 - 313.1; EPS: $0.63 - 0.89; non-GAAP EPS: $2.68 - 2.94.</li><li><strong>Q1 guidance</strong>: net service revenue: $751.0M - 781.0M; non-GAAP net income: $56.6M - 63.5M; EPS: ($0.03) - 0.04; non-GAAP EPS: $0.54 - 0.60.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335183\" data-linked=\"Syneos Q4 top line up 165%; non-GAAP earnings up 66%; shares up 18%\" data-tweet=\"$SYNH - Syneos Q4 top line up 165%; non-GAAP earnings up 66%; shares up 18% https://seekingalpha.com/news/3335183-syneos-q4-top-line-up-165-non-gaap-earnings-up-66-shares-up-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3335183-syneos-q4-top-line-up-165-non-gaap-earnings-up-66-shares-up-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335178\" data-ts=\"1519834574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335178-acadia-down-17-after-q4-nuplazid-sales-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACADIA down 17% after Q4 Nuplazid sales disappoint</a></h4><ul><li>ACADIA Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-16.6%</font>) slumps on over triple normal volume after it posted <a href=\"https://seekingalpha.com/pr/17086628-acadia-pharmaceuticals-reports-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Q4 results</a> yesterday after the close. Revenue of $43.6M was a bit shy of consensus (<font color='red'>-0.72M</font>).</li><li>NUPLAZID (pimavanserin) accounted for all sales. Its Q4 tally was up 263% yoy. The company expects NUPLAZID to generate $255M - 270M in sales this year. Consensus view is currently ~$260M. Q1 sales should be $45M - 48M, up ~7% sequentially (midpoint).</li></ul><div class=\"tiny-share-widget\" data-id=\"3335178\" data-linked=\"ACADIA down 17% after Q4 Nuplazid sales disappoint\" data-tweet=\"$ACAD - ACADIA down 17% after Q4 Nuplazid sales disappoint https://seekingalpha.com/news/3335178-acadia-down-17-after-q4-nuplazid-sales-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3335178-acadia-down-17-after-q4-nuplazid-sales-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335174\" data-ts=\"1519834143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335174-sinclair-broadcast-groupminus-6_9-revenues-fade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast Group -6.9% as revenues fade</a></h4><ul>   <li>Sinclair Broadcast Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a>) is <font color='red'>6.9% lower</font> this morning after <a href=\"https://seekingalpha.com/news/3335035-sinclair-broadcast-eps-4_32\" target=\"_blank\">Q4 earnings</a> that were boosted by tax effects but which saw an 8% revenue decline in an off-year for political advertising.</li>       <li>Net income of $443.5M was up from a prior $120.9M, but included a $272M nonrecurring tax benefit due to new legislation, along with a $225M gain recognized for vacating spectrum in some markets.</li>    <li>Revenues from digital businesses were up 64% Y/Y.</li>    <li>Excluding political business, market share was roughly flat Y/Y.</li>    <li>Revenue breakout: Media revenues, $685.4M (down 5.7%); Revenues from station barter, $29.1M (down 32%); Other nonmedia revenues, $19.5M (down 30.5%).</li>    <li>For Q1, it's guiding to media revenues of $638M-$644M (up 5.2%-6.2%), with political revenues expected to quadruple to $8M. It sees total capex at around $42M, with $8M tied to the spectrum repack and likely reimbursed by government.</li>    <li>For the full year, it expects capex of $179M-$189M, with $69M reimbursable and related to the repack.</li>    <li><a href=\"https://seekingalpha.com/pr/17087196-sinclair-declares-0_18-per-share-quarterly-cash-dividend\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3335174\" data-linked=\"Sinclair Broadcast Group -6.9% as revenues fade\" data-tweet=\"$SBGI - Sinclair Broadcast Group -6.9% as revenues fade https://seekingalpha.com/news/3335174-sinclair-broadcast-groupminus-6_9-revenues-fade?source=tweet\" data-url=\"https://seekingalpha.com/news/3335174-sinclair-broadcast-groupminus-6_9-revenues-fade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335162\" data-ts=\"1519833721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335162-healthcare-top-5-gainers-losers-of-11-00-2-28-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/28/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/IVTY' title='Invuity'>IVTY</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/HSKA' title='Heska Corporation'>HSKA</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335162\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/28/2018)\" data-tweet=\"$ECYT $ECYT $FPRX - Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/28/2018) https://seekingalpha.com/news/3335162-healthcare-top-5-gainers-losers-of-11-00-2-28-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3335162-healthcare-top-5-gainers-losers-of-11-00-2-28-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335170\" data-ts=\"1519833648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APEI\" target=\"_blank\">APEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335170-american-public-education-soars-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Public Education soars after earnings</a></h4><ul> <li>It's a post-earnings rally for American Public Education (<a href='https://seekingalpha.com/symbol/APEI' title='American Public Education, Inc.'>APEI</a> <font color='green'>+20.6%</font>) after the company brings in revenue of $78M in Q4.</li><li>Net course registrations were down 3% to 80.3K.</li>  <li>The company's revenue guidance for Q1 was for a tally of ~$73.43M to $76.56M (-3% to +1%), which has a midpoint just short of the consensus estimate of $74.58. EPS of $0.29-$0.34 is expected vs. $0.28 consensus.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3334758-american-public-education-beats-0_18-beats-revenue\" target=\"_blank\">American Public Education beats by $0.18, beats on revenue</a> (Feb. 27)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3335170\" data-linked=\"American Public Education soars after earnings\" data-tweet=\"$APEI - American Public Education soars after earnings https://seekingalpha.com/news/3335170-american-public-education-soars-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3335170-american-public-education-soars-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335166\" data-ts=\"1519833156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335166-needham-microsemi-acquisition-be-immediately-accretive-for-mchp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham: Microsemi acquisition could be &quot;immediately accretive&quot; for MCHP</a></h4><ul><li>        Needham thinks the potential Microchip Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>) acquisition of Microsemi (NASDAQ:<a href='https://seekingalpha.com/symbol/MSCC' title='Microsemi Corporation'>MSCC</a>) could be immediately accretive and add $1.27 in non-GAAP EPS over two years.</li><li>               Firm sees the potential for $200M in synergies and combined CY19 EPS of $7.70.&nbsp;</li><li>               Needham thinks the news timing is due to tomorrow&rsquo;s analyst day and follows weak guidance in the last earnings report.&nbsp;</li><li>               Firm expects the deal to open new end markets including aerospace, defense, and datacenter.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Microchip shares are&nbsp;<font color='green'>up 1.6%</font>.&nbsp;</li><li>               Microsemi shares are&nbsp;<font color='red'>down 0.2%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334410-microchip-technology-nears-deal-microsemi\" target=\"_blank\">Microchip Technology nears deal for Microsemi</a> (Feb. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335166\" data-linked=\"Needham: Microsemi acquisition could be &quot;immediately accretive&quot; for MCHP\" data-tweet=\"$MCHP $MCHP $MSCC - Needham: Microsemi acquisition could be &quot;immediately accretive&quot; for MCHP https://seekingalpha.com/news/3335166-needham-microsemi-acquisition-be-immediately-accretive-for-mchp?source=tweet\" data-url=\"https://seekingalpha.com/news/3335166-needham-microsemi-acquisition-be-immediately-accretive-for-mchp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335164\" data-ts=\"1519833046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARA\" target=\"_blank\">CARA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335164-cara-therapeutics-launches-early-stage-study-of-korsuva-in-liver-disease-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cara Therapeutics launches early-stage study of Korsuva in liver disease; shares up 2%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17087156-cara-therapeutics-doses-first-patient-phase-1-trial-oral-korsuva-cr845-difelikefalin-chronic\" target=\"_blank\">Dosing is underway</a> in a Phase 1 study evaluating the safety and pharmacokinetics of Cara Therapeutics' (<a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='green'>+2.3%</font>) Oral KORSUVA (difelikefalin) in patients with chronic liver disease &#40;CLD&#41;. The open-label trial will enroll up to 60 subjects with CLD and up to 12 healthy patients for control.</li><li>Results will inform the design of a Phase 2 clinical trial in patients with moderate-to-severe CLD-associated pruritis.</li><li>KORSUVA is a peripherally acting&nbsp;<a href=\"http://www.caratherapeutics.com/pipeline-technology/kappa-opioid-receptor-agonists/\" target=\"_blank\">kappa opioid receptor agonist</a>&nbsp;that is also being developed for the treatment of acute and chronic pain. Its value proposition is opioid-like analgesia without the respiratory depression or intestinal tract inhibition (constipation).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3326747-cara-therapeutics-launches-late-stage-study-cr845-ckd-ap\" target=\"_blank\">Cara Therapeutics launches late-stage study of CR845 in CKD-aP</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335164\" data-linked=\"Cara Therapeutics launches early-stage study of Korsuva in liver disease; shares up 2%\" data-tweet=\"$CARA - Cara Therapeutics launches early-stage study of Korsuva in liver disease; shares up 2% https://seekingalpha.com/news/3335164-cara-therapeutics-launches-early-stage-study-of-korsuva-in-liver-disease-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3335164-cara-therapeutics-launches-early-stage-study-of-korsuva-in-liver-disease-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335155\" data-ts=\"1519832005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335155-endocyte-prices-stock-offering-4_20-shares-up-30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endocyte prices stock offering at $4.20; shares up 30%</a></h4><ul><li>Endocyte (<a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='green'>+29.8%</font>) <a href=\"https://seekingalpha.com/pr/17087645-endocyte-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of ~17.9M shares of common stock at $4.20 per share, yesterday's closing price. Underwriters over-allotment is an additional ~2.7M shares. Closing date is March 2.</li><li>Net proceeds will fund the pipeline development, working capital and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335155\" data-linked=\"Endocyte prices stock offering at $4.20; shares up 30%\" data-tweet=\"$ECYT - Endocyte prices stock offering at $4.20; shares up 30% https://seekingalpha.com/news/3335155-endocyte-prices-stock-offering-4_20-shares-up-30?source=tweet\" data-url=\"https://seekingalpha.com/news/3335155-endocyte-prices-stock-offering-4_20-shares-up-30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335148\" data-ts=\"1519831572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNCE\" target=\"_blank\">LNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335148-on-snyders-lances-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Snyder&#39;s-Lance&#39;s Q4 miss</a></h4><ul><li>Snyder's-Lance (<a href='https://seekingalpha.com/symbol/LNCE' title='Snyder&#39;s-Lance, Inc.'>LNCE</a>) reports core brands growth of 1.1% to $404.69M in <a href=\"https://seekingalpha.com/pr/17087316-snyder-s-lance-inc-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4</a>.</li><li>Allied brands down 3.7% to $41.1M.</li><li>Adjusted gross margin rate squeezed 120 bps to 36.1%.</li><li>SG&amp;A expense rate -1300 bps to 27.3%.</li><li>Adjusted operating margin rate improved 50 bps to 9.9%.</li><li>Adjusted EBITDA increased 1.8% to $78.47M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335148\" data-linked=\"More on Snyder&#39;s-Lance&#39;s Q4 miss\" data-tweet=\"$LNCE - More on Snyder&#39;s-Lance&#39;s Q4 miss https://seekingalpha.com/news/3335148-on-snyders-lances-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3335148-on-snyders-lances-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335145\" data-ts=\"1519831109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335145-biocryst-commences-long-term-safety-study-of-bcx7353-in-hae-patients-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCryst commences long-term safety study of BCX7353 in HAE patients; shares up 2%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17087041-biocryst-announces-initiation-apex-s-long-term-safety-trial-bcx7353-patients-hereditary\" target=\"_blank\">Dosing is underway</a> in a long-term safety trial, APeX-S, assessing BioCryst Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a> <font color='green'>+1.7%</font>) BCX7353 as a preventative treatment in patients with hereditary angioedema &#40;HAE&#41;. The open-label two-arm study will evaluate the safety of two dose levels (110 mg and 150 mg once daily) over 48 weeks in ~160 patients with Type I and Type II HAE.</li><li>The results will supplement the efficacy and safety data generated in the Phase 3 APeX-2 study that will commence shortly.</li><li>BCX7353 is a selective inhibitor of plasma kallikrein.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3284434-biocryst-launches-new-mid-stage-study-evaluating-hae-candidate-bcx7353\" target=\"_blank\">BioCryst launches new mid-stage study evaluating HAE candidate BCX7353</a> (Aug. 2, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335145\" data-linked=\"BioCryst commences long-term safety study of BCX7353 in HAE patients; shares up 2%\" data-tweet=\"$BCRX - BioCryst commences long-term safety study of BCX7353 in HAE patients; shares up 2% https://seekingalpha.com/news/3335145-biocryst-commences-long-term-safety-study-of-bcx7353-in-hae-patients-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3335145-biocryst-commences-long-term-safety-study-of-bcx7353-in-hae-patients-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335144\" data-ts=\"1519831052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335144-3d-printing-stocks-drop-after-stratasys-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D printing stocks drop after Stratasys earnings</a></h4><ul><li>3D printing stocks drop after the earnings report of peer Stratasys (<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a> <font color='red'>-8.7%</font>).</li><li>On the move: Proto Labs (<a href='https://seekingalpha.com/symbol/PRLB' title='Proto Labs'>PRLB</a> <font color='red'>-5.3%</font>), 3D Systems (<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a> <font color='red'>-3.7%</font>), and ExOne (<a href='https://seekingalpha.com/symbol/XONE' title='ExOne'>XONE</a> <font color='red'>-0.6%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335038-stratasys-minus-7-percent-q4-beats-downside-eps-guide\" target=\"_blank\">Stratasys -7% after Q4 beats, downside EPS guide</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335144\" data-linked=\"3D printing stocks drop after Stratasys earnings\" data-tweet=\"$SSYS $SSYS $PRLB - 3D printing stocks drop after Stratasys earnings https://seekingalpha.com/news/3335144-3d-printing-stocks-drop-after-stratasys-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3335144-3d-printing-stocks-drop-after-stratasys-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335139\" data-ts=\"1519830534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHPI\" target=\"_blank\">AHPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335139-allied-healthcare-products-continues-rally-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allied Healthcare Products continues rally, up 20%</a></h4><ul><li>Thinly traded nano cap Allied Healthcare Products (<a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+20.3%</font>) is up on a 23x surge in volume in early trade. Shares have doubled since last week.</li><li>No particular news accounts for the action. At <a href=\"https://www.sec.gov/Archives/edgar/data/874710/000114420418009053/tv485561_10q.htm#a_003\" target=\"_blank\">year-end 2017</a>, the company only had $800 in cash. Receivables were ~$3.6M. Operations consumed ~$995K over the last six months of 2017. The company has to bring in what's owed or raise additional capital.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335139\" data-linked=\"Allied Healthcare Products continues rally, up 20%\" data-tweet=\"$AHPI - Allied Healthcare Products continues rally, up 20% https://seekingalpha.com/news/3335139-allied-healthcare-products-continues-rally-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3335139-allied-healthcare-products-continues-rally-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335140\" data-ts=\"1519830439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335140-microsoft-pushes-healthcare-new-azure-tool-cloud-blueprints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft pushes into healthcare with new Azure tool, cloud blueprints</a></h4><ul><li>        Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) <a href=\"https://www.bloomberg.com/news/articles/2018-02-28/microsoft-looks-to-lure-health-care-companies-to-its-cloud-with-new-tools\" target=\"_blank\">unveils</a> an Azure cloud platform tool for gene analysis for use at locations like St. Jude Children&rsquo;s Research Hospital, which is already using the tech.</li><li>                  Microsoft also has a blueprint to walk firms into moving health data onto the cloud without violating HIPAA privacy laws.    </li><li>               The tech giant will also help companies use its Teams enterprise chat program while adhering to privacy and data rules.&nbsp;</li><li>               Microsoft has the machine learning-backed Project Empower MD tool that transcribes patient and doctor conversations and key appointment moments into a standardized format.&nbsp;</li><li>               Microsoft wants to push itself as a potential healthcare partner instead of a rival, which is what cloud competitor Amazon could run into with its own healthcare product and service efforts.&nbsp;</li><li>               Microsoft shares are&nbsp;<font color='green'>up 1.1%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334241-berkshire-amazon-jpmorgan-healthcare-venture-just-pricing-power-buffett\" target=\"_blank\">Berkshire-Amazon-JPMorgan healthcare venture more than just pricing power - Buffett</a> (Feb. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335140\" data-linked=\"Microsoft pushes into healthcare with new Azure tool, cloud blueprints\" data-tweet=\"$MSFT - Microsoft pushes into healthcare with new Azure tool, cloud blueprints https://seekingalpha.com/news/3335140-microsoft-pushes-healthcare-new-azure-tool-cloud-blueprints?source=tweet\" data-url=\"https://seekingalpha.com/news/3335140-microsoft-pushes-healthcare-new-azure-tool-cloud-blueprints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335133\" data-ts=\"1519829871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335133-acorda-inks-deal-activist-investor-allows-two-board-seats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda inks deal with activist investor, allows two board seats</a></h4><ul><li>Acorda Therapeutics (<a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-1.9%</font>) enters into a cooperation <a href=\"https://seekingalpha.com/pr/17087134-acorda-enters-cooperation-agreement-scopia\" target=\"_blank\">agreement </a>with Scopia Capital Management LP agreeing to allow the investor to appoint two board members while supporting the company's nominees. The agreement is effective through January 1, 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3332380-fda-accepts-acordas-marketing-application-parkinsons-med-inbrija-action-date-october-5\" target=\"_blank\">FDA accepts Acorda's marketing application for Parkinson's med Inbrija, action date October 5</a> (Feb. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3335133\" data-linked=\"Acorda inks deal with activist investor, allows two board seats\" data-tweet=\"$ACOR - Acorda inks deal with activist investor, allows two board seats https://seekingalpha.com/news/3335133-acorda-inks-deal-activist-investor-allows-two-board-seats?source=tweet\" data-url=\"https://seekingalpha.com/news/3335133-acorda-inks-deal-activist-investor-allows-two-board-seats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335131\" data-ts=\"1519829705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIHD\" target=\"_blank\">NIHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335131-nii-holdingsplus-11_4-kills-nextel-brazil-investment-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NII Holdings +11.4% as it kills Nextel Brazil investment deal</a></h4><ul>   <li>NII Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a>) is <font color='green'>up 11.4%</font> this morning following its filing noting it's <a href=\"https://www.sec.gov/Archives/edgar/data/1037016/000103701618000002/nihd-icegroupterminationx8.htm\" target=\"_blank\">terminating an investment agreement</a> with AINMT Holdings from last summer that allowed AINMT to partner in the ownership of Nextel Brazil.</li>    <li>AINMT (also known as \"ice group\") didn't exercise an option to make a second investment by the option exercise date of Nov. 15 and didn't complete that second investment by a Jan. 31 termination date, allowing for terminating the agreement, NII Holdings says.</li>    <li>Ice group was to partner in owning Nextel Brazil through an initial $50M investment for 30% ownership in Nextel Holdings, followed by the option to invest an additional $150M (to end up with a 60% stake).</li>    <li>Shares in NII Holdings are up 132% on Nasdaq since last Friday, when reports emerged that Brazilian regulators were <a href=\"https://seekingalpha.com/news/3333927-nii-holdings-jumps-alongside-brazil-regulators-spectrum-cap-moves\" target=\"_blank\">looking at lifting spectrum caps</a>, a move that would spur consolidation in a competitive telecom sector.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335131\" data-linked=\"NII Holdings +11.4% as it kills Nextel Brazil investment deal\" data-tweet=\"$NIHD - NII Holdings +11.4% as it kills Nextel Brazil investment deal https://seekingalpha.com/news/3335131-nii-holdingsplus-11_4-kills-nextel-brazil-investment-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3335131-nii-holdingsplus-11_4-kills-nextel-brazil-investment-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335130\" data-ts=\"1519829686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GXYEF\" target=\"_blank\">GXYEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335130-union-gaming-sees-upside-on-galaxy-entertainment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Union Gaming sees upside on Galaxy Entertainment</a></h4><ul> <li>Union Gaming sizes up Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>, <a href='https://seekingalpha.com/symbol/GXYEY' title='Galaxy Entertainment Group, Ltd. ADR'>OTCPK:GXYEY</a>) after the casino operator's strong Q4 report (revenue +25%, EBITDA +40%).</li> <li>\"Galaxy continues to outperform the market, generally by significant margins, across all relevant gaming segments. With the high end of the market still performing very well, we look for Galaxy to remain in high growth mode,\" writes analyst Grant Govertsen.</li> <li>Union reiterates a Buy rating on Galaxy and takes its price target up to HKD$86 from $HKD66. Shares of Galaxy closed at HKD$68.50 in Hong Kong today.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3335130\" data-linked=\"Union Gaming sees upside on Galaxy Entertainment\" data-tweet=\"$GXYEF $GXYEF $GXYEY - Union Gaming sees upside on Galaxy Entertainment https://seekingalpha.com/news/3335130-union-gaming-sees-upside-on-galaxy-entertainment?source=tweet\" data-url=\"https://seekingalpha.com/news/3335130-union-gaming-sees-upside-on-galaxy-entertainment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335129\" data-ts=\"1519829157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGR\" target=\"_blank\">RGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335129-dicks-assault-rifle-decision-hangs-over-firearms-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dick&#39;s assault rifle decision hangs over firearms sector</a></h4><ul> <li>Sturm, Ruger (NYSE:<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a>) is&nbsp;<font color='red'>down 1.95%</font>&nbsp;and American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) drifts&nbsp;<font color='red'>1.29% lower</font>&nbsp;after Dick's announces that it won't sell assault-style rifles at its stores any longer.</li> <li>The move by Dick's is considered by analysts more meaningful than the removal of NRA discounts by some companies in the travel industry</li> <li>Vista Outdoor (NYSE:<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a>), which is facing some boycott pressure of is own, is&nbsp;<font color='red'>down 1.27%</font>&nbsp;in early trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335020-dicks-sporting-goods-ends-sale-assault-rifles\" target=\"_blank\">Dick's Sporting Goods ends sale of assault rifles</a> (Feb. 28)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3335129\" data-linked=\"Dick&#39;s assault rifle decision hangs over firearms sector\" data-tweet=\"$RGR $RGR $AOBC - Dick&#39;s assault rifle decision hangs over firearms sector https://seekingalpha.com/news/3335129-dicks-assault-rifle-decision-hangs-over-firearms-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3335129-dicks-assault-rifle-decision-hangs-over-firearms-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335126\" data-ts=\"1519828694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335126-macys-tracks-higher-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s tracks higher again</a></h4><ul> <li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) is&nbsp;<font color='green'>up another 2.8%</font>&nbsp;in early trading to follow on yesterday's post-earnings rip.</li> <li>Investors are ahead of the sell-side analysts in backing a Macy's comeback. Telsey keeps a Market Perform rating on the retailer, calling it a \"show-me' story. RBC Capital sticks with a Sector Perform rating, while boosting its price target to $31.</li> <li>Macy's currently trades at a 10-month high.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3334628-macys-plus-12-percent-posting-impressive-quarter\" target=\"_blank\">Macy's +12% after posting impressive quarter</a> (Feb. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3335126\" data-linked=\"Macy&#39;s tracks higher again\" data-tweet=\"$M - Macy&#39;s tracks higher again https://seekingalpha.com/news/3335126-macys-tracks-higher-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3335126-macys-tracks-higher-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3335125\" data-ts=\"1519828534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3335125-herbalife-to-change-name-to-herbalife-nutrition-2-1-stock-split-and-stock-buyback-planned\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herbalife to change name to Herbalife Nutrition; 2:1 stock split and stock buyback planned; shares up 2%</a></h4><ul><li>Aimed at boosting shareholder value, Herbalife (<a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a> <font color='green'>+2%</font>) <a href=\"https://seekingalpha.com/pr/17087565-herbalife-announces-strategic-initiatives-enhance-shareholder-value\" target=\"_blank\">announces </a>its plan to reacquire $450M - 650M of its common stock via a \"modified Dutch auction\" offer. It also plans to refinance a portion of its outstanding $1.15B Convertible Notes due August 15, 2019, giving it more flexibility in deploying its capital.</li><li>It plans to split its common stock 2:1 and change its corporate name to Herbalife Nutrition Ltd. subject to shareholder approval in late April.</li></ul><div class=\"tiny-share-widget\" data-id=\"3335125\" data-linked=\"Herbalife to change name to Herbalife Nutrition; 2:1 stock split and stock buyback planned; shares up 2%\" data-tweet=\"$HLF - Herbalife to change name to Herbalife Nutrition; 2:1 stock split and stock buyback planned; shares up 2% https://seekingalpha.com/news/3335125-herbalife-to-change-name-to-herbalife-nutrition-2-1-stock-split-and-stock-buyback-planned?source=tweet\" data-url=\"https://seekingalpha.com/news/3335125-herbalife-to-change-name-to-herbalife-nutrition-2-1-stock-split-and-stock-buyback-planned\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>208&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}